Option Care Health, Inc. provides home and alternate-site infusion services for patients with acute and chronic conditions across the United States. The company operates in infusion services and reports developments tied to clinical service delivery, national provider relationships, and the economics of its care model.
Recurring news for OPCH includes quarterly and full-year financial results, guidance updates, operating cash flow, share repurchase activity, credit facility changes, and presentations at health care investor conferences. Company updates also address capital allocation and management commentary related to revenue growth and profitability in home and alternate-site infusion care.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will announce its first-quarter results for the period ending March 31, 2023, on May 4, 2023, prior to market opening.
Following this announcement, management will host a conference call at 8:30 a.m. ET to discuss the results. Interested parties can join by calling 800-445-7795 (U.S.) or 785-424-1699 (international), using conference ID “OPCH Q123.” A live audio webcast will also be available, along with a replay for on-demand listening shortly after the call.
With over 7,500 team members, including more than 4,500 clinicians, Option Care Health remains focused on enhancing patient care across all 50 states. For further details, visit OptionCareHealth.com.
Walgreens Boots Alliance (WBA) has sold approximately 15.5 million shares of Option Care Health (OPCH), raising funds at $30.75 per share. This includes 13.0 million shares in an underwritten secondary offering and a concurrent repurchase of 2.5 million shares by OPCH. Following the sale, WBA's ownership in OPCH decreased from 14% to 6%. The proceeds will primarily be allocated for debt paydown and to support WBA's strategic initiatives.